Summary
CVS Health Corporation announced a significant definitive agreement to merge with Aetna Inc. in a transaction valued at approximately $69 billion. Under the terms of the merger agreement, Aetna shareholders will receive a combination of cash and CVS Health stock for each Aetna share, specifically 0.8378 shares of CVS Health common stock and $145.00 in cash. This transformative deal aims to create a combined entity with a substantial presence in both pharmacy benefit management and healthcare insurance. The filing also details the financing arrangements for the acquisition, including a commitment for a $49 billion bridge loan facility, underscoring the scale of the transaction. Key closing conditions include shareholder approvals from both companies, satisfactory regulatory clearances, and the absence of any legal impediments. Both companies' boards are recommending their respective shareholders approve the transaction.
Key Highlights
- 1CVS Health to acquire Aetna in a cash and stock transaction valued at approximately $69 billion.
- 2Aetna shareholders will receive 0.8378 CVS Health shares and $145.00 in cash per Aetna share.
- 3The merger aims to create a combined company with significant scale in pharmacy benefit management and health insurance.
- 4A $49 billion bridge loan facility has been committed to finance the acquisition.
- 5The transaction is subject to customary closing conditions, including shareholder and regulatory approvals.
- 6CVS Health's board will be expanded to include Aetna's CEO and two other Aetna directors.
- 7Both companies are required to obtain shareholder approval for the transaction.